AFAP1 and neoplasm: When AFAP1-AS1 was used as a prognosis biomarker, the areas under receiver operating characteristic (ROC) curves were 0.8669 and 0.9370 for the forecast of tumor growth during 6 months and 1 year, respectively [36].